Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia
Conditions
- Adult Myelodysplastic Syndrome
- Anemia
- Chronic Myelomonocytic Leukemia
Interventions
- DRUG: Eltrombopag Olamine
- OTHER: Laboratory Biomarker Analysis
- DRUG: Lenalidomide
Sponsor
Albert Einstein College of Medicine
Collaborators